483 Wuxi Apptec Biopharmaceuticals Aug 2017

483 Wuxi Apptec Biopharmaceuticals Aug 2017

Bo Chi FDA, Marion Michaelis FDA, Christopher Middendorf FDA$119.00 - Available Now

FDA investigators audited the Wuxi Apptec Biopharmaceuticals - Wuxi, China facility and issued inspectional observations (via FDA 483) on 02 Aug 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 02 Aug 2017
  • Location: Wuxi, China
  • FEI: 3010606982
Add To Cart